Here are seven updates since January 2020, starting with the most recent:
1. A partnership reached between Iterative Scopes and Eli Lilly Feb. 11 will explore how AI can improve understanding of inflammatory bowel disease pathophysiology and target identification. Iterative Scopes closed a $5.2 million seed round in January 2020.
2. Chattanooga, Tenn.-based Erlanger Health System started a clinical trial to test an AI device used to increase polyp detection during colonoscopies, according to a Feb. 9 report.
3. Docbot’s AI platform can be trained to predict how severe ulcerative colitis is after reviewing endoscopy videos, according to a Nov. 10 report.
4. A survey found nearly 90 percent of U.S. gastroenterologists are open to using AI to improve colonoscopies, according to a study published Sept. 22 in Endoscopy International Open.
5. FujiFilm launched an AI colon polyp device in Europe, according to a Sept. 21 report. It’s used with the company’s Eluxeo 7000 system to assist with colon polyp detection and characterization.
6. Rochester, Minn.-based Mayo Clinic researchers and NASA Frontier Development Lab scientists worked to fine-tune an AI algorithm to detect spatio-temporal patterns related to colorectal cancer progression, according to a Sept. 1 report.
7. A Chinese study examined the effect AI had on colonoscopy detection and found real-time quality systems improved the adenoma yield, according to a Jan. 28, 2020, report.
More articles on surgery centers:
12-OR ASC part of $295M Florida orthopedic hospital expansion
3 ASCs launching total joint programs
4 ASCs installing total joint robots
